Skip to main content
SpringerLink
Log in

Strategy to Achieve Full Coverage in the National Free Antiretroviral Therapy Program

  • Chapter
  • First Online:
HIV/AIDS in China

Abstract

The mode of HIV treatment in China is distinctive compared to the rest of the world—the Government of China is responsible for providing financial support to test and treat people living with HIV and lead the development of strategies to prevent and control the spread of HIV. Early in the epidemic, most people living with HIV were poor and could not afford treatment. In addition, the lack of physicians with experience in antiretroviral therapy (ART) was also a huge challenge before 2000. Numerous HIV infections were reported among former plasma donors infected at blood collection centers in the mid-1990s. Ten years since becoming infected, most people living with HIV developed AIDS and died in 2001–2002 due to lack of timely treatment. In response, the Chinese government piloted an emergency response program in high prevalence villages in Henan to provide free ART beginning in 2002. In 2003, Premier Wen Jiabao announced the “Four Frees and One Care” policy. In 2004, the Department of Treatment and Care at the National Center for AIDS/STD Control and Prevention (NCAIDS) commenced the development of an information system to track ART patients. China’s National Free ART Program (NFATP) has since been quickly scaled up. The eligibility criteria for initiating ART have been adjusted from CD4 cell count less than 200–350 cells/mm3 in 2008, then 500 cells/mm3 in 2014, and finally for all people living with HIV, regardless their CD4 cell count, in 2016. By the end of 2017, the NFATP had enrolled and provided ART for 609,829 people living with HIV (including 5669 pediatric patients), with a coverage of 80.4%. Overall mortality decreased from 18.4% in 2005 to 4.2% in 2015. China has had remarkable success in implementing HIV treatment, but there is still a long way to go to continue improve coverage and effectiveness of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Badri M, Ehrlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS. 2001;15:1143–8.

    Article  CAS  Google Scholar 

  • Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14:e1024–31.

    Article  Google Scholar 

  • Chen WT, Starks H, Shiu CS, Fredriksen-Goldsen K, Simoni J, Zhang F, Pearson C, Zhao H. Chinese HIV-positive patients and their healthcare providers: contrasting Confucian versus Western notions of secrecy and support. ANS Adv Nurs Sci. 2007;30:329–42.

    Article  Google Scholar 

  • Cohen MS, Chen YQ, Mccauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, De Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.

    Article  CAS  Google Scholar 

  • Cohen MS, Mccauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7:99–105.

    Article  CAS  Google Scholar 

  • Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382:1515–24.

    Article  CAS  Google Scholar 

  • Dou Z, Chen RY, Wang Z, et al. HIV-infected former plasma donors in rural Central China: from infection to survival outcomes,1985–2008. PLoS One. 2010a;5(10):e13737.

    Article  Google Scholar 

  • Dou Z, Chen RY, Xu J, et al. Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002–09. Int J Epidemiol. 2010b;39(Suppl 2):ii56–64.

    PubMed  PubMed Central  Google Scholar 

  • Gao L, Zhou F, Li X, Jin Q. HIV/TB co-infection in mainland China: a meta-analysis. PLoS One. 2010;5:e10736.

    Article  Google Scholar 

  • Hung CC, Hsueh PR, Chen MY, Hsiao CH, Chang SC, Luh KT. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis. 1998;26:202–3.

    Article  CAS  Google Scholar 

  • Jia Z, Mao Y, Zhang F, Ruan Y, Ma Y, Li J, Guo W, Liu E, Dou Z, Zhao Y, Wang L, Li Q, Xie P, Tang H, Han J, Jin X, Xu J, Xiong R, Zhao D, Li P, Wang X, Qing Q, Ding Z, Chen RY, Liu Z, Shao Y. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort study. Lancet. 2013;382:1195–203.

    Article  Google Scholar 

  • Kim JH, Psevdos G, Suh J, Sharp VL. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J Gastroenterol. 2008;14:6689–93.

    Article  Google Scholar 

  • Labarga P, Soriano V, Vispo ME, Pinilla J, Martin-Carbonero L, Castellares C, Casado R, Maida I, Garcia-Gasco P, Barreiro P. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. J Infect Dis. 2007;196:670–6.

    Article  CAS  Google Scholar 

  • Liu Y, Wu Z, Mao Y, et al. Quantitatively monitoring AIDS policy implementation in China. Int J Epidemiol. 2010;39(Suppl 2):ii90–6.

    PubMed  PubMed Central  Google Scholar 

  • Ma Y, Zhang F, Zhao Y, et al. Cohort profile: the Chinese national free antiretroviral treatment cohort. Int J Epidemiol. 2009;39:973–9.

    Article  Google Scholar 

  • Ma Y, Zhao D, Yu L, Bulterys M, Robinson ML, Zhao Y, Dou Z, Chiliade P, Wei X, Zhang F. Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China. Clin Infect Dis. 2010;50(2):264–71.

    Article  Google Scholar 

  • Ma Y, Dou Z, Guo W, Mao Y, Zhang F, Mcgoogan JM, Zhao Y, Zhao D, Wu Y, Liu Z, Wu Z. The human immunodeficiency virus care continuum in China: 1985–2015. Clin Infect Dis. 2018;66:833–9.

    Article  Google Scholar 

  • National Center for AIDS/STD Control and Prevention & Chinese Center for Disease Control and Prevention. 2017 National HIV/HCV/Syphilis prevention and treatment implementation report. National Provincial AIDS Directors Meeting, March 18, 2017. Ningbo. In: NCAIDS/China CDC; 2018.

    Google Scholar 

  • Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology. 2010;52:1143–55.

    Article  CAS  Google Scholar 

  • Philbin MM, Zhang F. Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China. AIDS Care. 2010;22:623–9.

    Article  Google Scholar 

  • Ranjana KH, Priyokumar K, Singh TJ, Gupta CH, Sharmila L, Singh PN, Chakrabarti A. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45:268–71.

    Article  CAS  Google Scholar 

  • Shiu CS, Chen WT, Simoni J, Fredriksen-Goldsen K, Zhang F, Zhou H. The Chinese Life-Steps Program: a cultural adaptation of a cognitive-behavioral intervention to enhance HIV medication adherence. Cogn Behav Pract. 2013;20:202–12.

    Article  Google Scholar 

  • Sohn AH, Srikantiah P, Sungkanuparph S, Zhang F. Transmitted HIV drug resistance in Asia. Curr Opin HIV AIDS. 2013;8:27–33.

    Article  CAS  Google Scholar 

  • Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, Lu F, Poundstone K. The development of HIV/AIDS surveillance in China. AIDS. 2007;21(Suppl 8):S33–8.

    Article  Google Scholar 

  • Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921–6.

    Article  Google Scholar 

  • UNAIDS. Treating 3 million by 2005, make it happen, the WHO strategy. Beijing: UNAIDS; 2003. p. 3–4.

    Google Scholar 

  • UNAIDS. UNAIDS report on the global AIDS epidemic 2013. Beijing: UNAIDS; 2013.

    Google Scholar 

  • Wang L, Wang N. HIV/AIDS epidemic and the development of comprehensive surveillance system in China with challenges. Chin Med J. 2010;123:3495–500.

    PubMed  Google Scholar 

  • Wang H, He G, Li X, Yang A, Chen X, Fennie KP, Williams AB. Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDs. 2008;22:71–80.

    Article  Google Scholar 

  • Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–41.

    Article  Google Scholar 

  • Wen Y, Zhao D, Dou Z, Ma Y, Zhao Y, Lu L, Liu W, Zhu H, Zhang F. Some patient-related factors associated with late access to ART in China’s free ART program. AIDS Care. 2011;23:1226–35.

    Article  Google Scholar 

  • Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346:612.

    Google Scholar 

  • Xia Liu YZ, Lan Y, Dou Z, Ma Y, Liu Z, Zhang F. Exploration of methodology of projecting annual demand for antiretroviral drugs in China. Chin J AIDS STD. 2011;17:291–4.

    Google Scholar 

  • Zhang F, J Pan LY, et al. Current progress of China’s free ART program. Cell Res. 2005;15(11–12):877–82.

    Article  Google Scholar 

  • Zhang F, Je H, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007;21(Suppl 8):S143–8.

    Article  Google Scholar 

  • Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151(4):241–51, W-52.

    Article  Google Scholar 

  • Zhang F, Dou Z, Ma Y, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516–24.

    Article  Google Scholar 

  • Zhang Y, Dou Z, Sun K, Ma Y, Chen RY, Bulterys M, Zhao Y, Zhu H, Liu Z, Zhang F. Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohort. J Acquir Immune Defic Syndr. 2012;60:59–67.

    Article  Google Scholar 

  • Zhang YJ, Fan YG, Dai SY, Li BZ, Xu WD, Hu LF, Liu J, Su H, Ye DQ. HIV/AIDS stigma among older PLWHA in south rural China. Int J Nurs Pract. 2014;21(3):221–8.

    Article  Google Scholar 

  • Zhao D, Ma Y, Zhang F, Gong W, Fang H, Zhao Y, Liu X, Sun X, Dou Z, Yu L, Liu Z, Li Y. Upgrading of the national antiretroviral therapy information system based on client/server structure in China. Chin J AIDS STD. 2013a;19:445–7.

    Google Scholar 

  • Zhao Y, Li C, Sun X, Mu W, Mcgoogan JM, He Y, Cheng Y, Tang Z, Li H, Ni M, Ma Y, Chen RY, Liu Z, Zhang F. Mortality and treatment outcomes of China’s National Pediatric antiretroviral therapy program. Clin Infect Dis. 2013b;56:735–44.

    Article  CAS  Google Scholar 

  • Zhu H, Napravnik S, Eron J, Cole S, Ma Y, Wohl D, Dou Z, Zhang Y, Liu Z, Zhao D, Cohen M, Zhang F. Attrition among human immunodeficiency virus (HIV)-infected patients initiating antiretroviral therapy in China, 2003–2010. PLoS One. 2012;7:e39414.

    Article  CAS  Google Scholar 

  • Zhu H, Napravnik S, Eron JJ, Cole SR, Ma Y, Wohl DA, Dou Z, Zhang Y, Liu Z, Zhao D, Yu L, Liu X, Cohen MS, Zhang F. Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003–2009. J Acquir Immune Defic Syndr. 2013;63:e150–7.

    Article  Google Scholar 

Download references

Acknowledgement

Authors would like thank Marc Bulterys and Jennifer M. McGoogan for their help in editing.

Author information

Authors and Affiliations

  1. NCAIDS, China CDC, Beijing, China

    Fujie Zhang, Ye Ma, Yan Zhao & Willa Dong

Authors
  1. Fujie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ye Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Willa Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fujie Zhang .

Editor information

Editors and Affiliations

  1. National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, China

    Zunyou Wu

  2. Chinese Center for Disease Control and Prevention (China CDC), Beijing, China

    Yu Wang

  3. Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA

    Roger Detels

  4. U.S. Centers for Disease Control and Prevention, Global AIDS Program, China Office, Beijing, China

    Marc Bulterys

  5. National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, China

    Jennifer M. McGoogan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhang, F., Ma, Y., Zhao, Y., Dong, W. (2020). Strategy to Achieve Full Coverage in the National Free Antiretroviral Therapy Program. In: Wu, Z., Wang, Y., Detels, R., Bulterys, M., McGoogan, J. (eds) HIV/AIDS in China. Springer, Singapore. https://doi.org/10.1007/978-981-13-8518-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-8518-6_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-8517-9

  • Online ISBN: 978-981-13-8518-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation